Annemarie Voss

5PUBLICATIONS
23CO-AUTHORS
PharmacogenomicsDental therapeutics, pharmacology and toxicologyHaematological tumoursAutonomic nervous systemElectrical energy generation (incl. renewables, excl. photovoltaics)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Mar 26, 2024
Challenges and lessons learned from a long-term postauthorisation safety study programme of rivaroxaban in Europe.

Gunnar Brobert, Ana Ruigomez, Tania Schink

|Jul 24, 2023
Risk Profiles of New Users of Oral Anticoagulants Between 2011 and 2019 in Germany.

Annemarie Voss, Bianca Kollhorst, Katharina Platzbecker

|Apr 04, 2023
In atrial fibrillation epilepsy risk differs between oral anticoagulants: active comparator, nested case-control study.

Katharina Platzbecker, Helge Müller-Fielitz, Ronja Foraita

|Feb 16, 2023
Safety and effectiveness of rivaroxaban for prevention of stroke in patients with nonvalvular atrial fibrillation: analysis of routine clinical data from four countries.

Luis Alberto García Rodríguez, Ana Ruigómez, Tania Schink

|Feb 01, 2023
Time Trends in Patient Characteristics of New Rivaroxaban Users with Atrial Fibrillation in Germany and the Netherlands.

Annemarie Voss, Elisabeth Smits, Karin M A Swart

Pageof 1

Frequent Collaborators

4 joint publications

Tania Schink

3 joint publications

Elisabeth Smits

3 joint publications

Yanina Balabanova

3 joint publications

Gunnar Brobert